Literature DB >> 3673496

Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage.

O Jensson1, G Gudmundsson, A Arnason, H Blöndal, I Petursdottir, L Thorsteinsson, A Grubb, H Löfberg, D Cohen, B Frangione.   

Abstract

Hereditary CNS amyloid angiopathy occurring in Icelanders is the first human disorder known to be caused by deposition of cystatin C amyloid fibrils in the walls of the brain arteries leading to single or or multiple strokes with fatal outcome. One or more affected members have been verified by histological examination in 8 families containing 127 affected. These originated from the same geographic area. Abnormally low value of cystatin C found in the cerebrospinal fluid of those affected can be used to support or make diagnosis of this disease, also in asymptomatic relatives. By amino acid sequence analysis the amyloid fibrils in the patients are found to be a variant of cystatin C (gamma-trace), a major cysteine proteinase inhibitor. The variant protein has an amino acid substitution (glutamine for leucine) at position 58 in the amyloid molecule. It is postulated that a point mutation has occurred leading to production of amyloidogenic protein causing the disorder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3673496     DOI: 10.1111/j.1600-0404.1987.tb03553.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  20 in total

1.  Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily.

Authors:  R A Staniforth; S Giannini; L D Higgins; M J Conroy; A M Hounslow; R Jerala; C J Craven; J P Waltho
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 2.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

Review 3.  Cystatin superfamily.

Authors:  Josiah Ochieng; Gautam Chaudhuri
Journal:  J Health Care Poor Underserved       Date:  2010-02

4.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

5.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

6.  Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.

Authors:  M Bjarnadottir; B S Wulff; M Sameni; B F Sloane; D Keppler; A Grubb; M Abrahamson
Journal:  Mol Pathol       Date:  1998-12

7.  Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.

Authors:  B Asgeirsson; S Haebel; L Thorsteinsson; E Helgason; K O Gudmundsson; G Gudmundsson; P Roepstorff
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

8.  Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

Authors:  M Abrahamson; A Grubb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis.

Authors:  M Abrahamson; S Jonsdottir; I Olafsson; O Jensson; A Grubb
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

10.  Morphological evaluation of amyloid-laden arteries in leptomeninges, cortices and subcortices in cerebral amyloid angiopathy with subcortical hemorrhage.

Authors:  N Iwamoto; T Ishihara; H Ito; F Uchino
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.